Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Unity Biotechnology, Inc. (UBX)
since 2018 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Unity Biotechnology, Inc..
Table 2 shows the detailed insider transactions.
This company's CIK number is 1463361.
Total stock buying since 2018: $28,476.
Total stock sales since 2018: $9,141,270.
Total stock option exercises since 2018: $119,450.
Table 3. Detailed insider trading at Unity Biotechnology, Inc. (UBX)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2025-04-02 | Nguyen Alexander Hieu (CLO and Head of Ops) | Sale | 17,852 | 1.03 | 18,387 |
| 2025-04-02 | Ghosh Anirvan (Chief Executive Officer) | Sale | 96,797 | 1.03 | 99,700 |
| 2025-04-02 | Sullivan Lynne Marie (CFO & Head of Corp. Dev.) | Sale | 21,867 | 1.03 | 22,523 |
| 2025-03-27 | Nguyen Alexander Hieu (CLO and Head of Ops) | Sale | 1,954 | 1.16 | 2,266 |
| 2025-02-04 | Nguyen Alexander Hieu (CLO and Head of Ops) | Sale | 164 | 2.23 | 365 |
| 2025-02-04 | Ghosh Anirvan (Chief Executive Officer) | Sale | 642 | 2.23 | 1,431 |
| 2025-02-04 | Sullivan Lynne Marie (CFO & Head of Corp. Dev.) | Sale | 153 | 2.23 | 341 |
| 2024-11-04 | Nguyen Alexander Hieu (Chief Legal Officer) | Sale | 149 | 1.29 | 192 |
| 2024-11-04 | Ghosh Anirvan (Chief Executive Officer) | Sale | 432 | 1.29 | 557 |
| 2024-11-04 | Sullivan Lynne Marie (CFO & Head of Corp. Dev.) | Sale | 136 | 1.29 | 175 |
| 2024-08-02 | Nguyen Alexander Hieu (Chief Legal Officer) | Sale | 154 | 1.53 | 235 |
| 2024-08-02 | Ghosh Anirvan (Chief Executive Officer) | Sale | 604 | 1.53 | 924 |
| 2024-08-02 | Sullivan Lynne Marie (CFO & Head of Corp. Dev.) | Sale | 139 | 1.53 | 212 |
| 2024-06-25 | Nguyen Alexander Hieu (Chief Legal Officer) | Sale | 78 | 1.40 | 109 |
| 2024-06-25 | Ghosh Anirvan (Chief Executive Officer) | Sale | 1,214 | 1.40 | 1,699 |
| 2024-06-25 | Sullivan Lynne Marie (CFO & Head of Corp. Dev.) | Sale | 324 | 1.40 | 453 |
| 2024-05-02 | Ghosh Anirvan (Chief Executive Officer) | Sale | 603 | 1.55 | 934 |
| 2024-02-02 | Ghosh Anirvan (Chief Executive Officer) | Sale | 680 | 1.71 | 1,162 |
| 2024-01-30 | Ghosh Anirvan (Chief Executive Officer) | Sale | 1,183 | 1.71 | 2,022 |
| 2023-11-02 | Ghosh Anirvan (Chief Executive Officer) | Sale | 589 | 1.83 | 1,077 |
| 2023-10-30 | Ghosh Anirvan (Chief Executive Officer) | Sale | 1,024 | 1.90 | 1,945 |
| 2023-09-14 | Ghosh Anirvan (Chief Executive Officer) | Sale | 1,246 | 2.47 | 3,077 |
| 2023-08-02 | Ghosh Anirvan (Chief Executive Officer) | Sale | 581 | 2.94 | 1,708 |
| 2023-07-31 | Ghosh Anirvan (Chief Executive Officer) | Sale | 1,020 | 2.86 | 2,917 |
| 2023-06-26 | Ghosh Anirvan (Chief Executive Officer) | Sale | 1,177 | 3.20 | 3,766 |
| 2023-06-14 | Ghosh Anirvan (Chief Executive Officer) | Sale | 1,212 | 3.39 | 4,108 |
| 2023-05-02 | Ghosh Anirvan (Chief Executive Officer) | Sale | 588 | 2.17 | 1,275 |
| 2023-05-01 | Ghosh Anirvan (Chief Executive Officer) | Sale | 1,020 | 2.15 | 2,193 |
| 2023-03-31 | Ghosh Anirvan (Chief Executive Officer) | Sale | 1,959 | 1.70 | 3,330 |
| 2023-03-31 | Dananberg Jamie (Chief Medical Officer) | Sale | 420 | 1.70 | 714 |
| 2023-03-14 | Ghosh Anirvan (Chief Executive Officer) | Sale | 1,210 | 4.00 | 4,840 |
| 2023-02-02 | Ghosh Anirvan (Chief Executive Officer) | Sale | 2,573 | 4.84 | 12,453 |
| 2023-02-02 | Dananberg Jamie (Chief Medical Officer) | Sale | 863 | 4.84 | 4,176 |
| 2023-01-30 | Ghosh Anirvan (Chief Executive Officer) | Sale | 1,140 | 4.45 | 5,073 |
| 2022-11-03 | Ghosh Anirvan (Chief Executive Officer) | Sale | 1,099 | 2.40 | 2,637 |
| 2022-09-14 | Dananberg Jamie (Chief Medical Officer) | Sale | 10,923 | .48 | 5,243 |
| 2022-08-01 | Ghosh Anirvan (Chief Executive Officer) | Sale | 10,446 | .67 | 6,998 |
| 2022-06-27 | Ghosh Anirvan (Chief Executive Officer) | Sale | 12,149 | .59 | 7,167 |
| 2022-06-27 | Dananberg Jamie (Chief Medical Officer) | Sale | 4,398 | .59 | 2,594 |
| 2022-06-21 | Dananberg Jamie (Chief Medical Officer) | Sale | 3,697 | .62 | 2,292 |
| 2020-12-16 | David Nathaniel E (President) | Sale | 1,700,000 | 5.24 | 8,908,000 |
| 2020-06-05 | David Nathaniel E (President) | Buy | 3,200 | 8.90 | 28,476 |
| 2020-02-24 | Goeltz Ii Robert C. (Chief Financial Officer) | Option Ex | 10,000 | 3.43 | 34,300 |
| 2019-06-19 | Leonard Keith R (Chief Executive Officer) | Option Ex | 20,000 | 3.40 | 68,000 |
| 2018-10-10 | Goeltz Ii Robert C. (Chief Financial Officer) | Option Ex | 5,000 | 3.43 | 17,150 |
Insider trading activities including stock purchases, stock sales, and option exercises
of UBX listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Unity Biotechnology, Inc. (symbol UBX,
CIK number 1463361) see
the Securities and Exchange Commission (SEC) website.